Ipsen S.A. (0MH6)
LSE
Real-time Data
07:00 AM
Day's Range
161.1052 wk Range
101.90Overview - 0MH6 - Ipsen S.A.
Key Statistics
Valuation
Enterprise Value
9.66B
P/E (Trailing)
‪33.81‬
Price / Sales (TTM)
‪4.45‬
Price / Book
‪4.00‬
EV / EBITDA
‪9.08‬
Profitability
Profit Margin
‪13.69%‬
Operating Margin
‪26.53%‬
Return on Assets
‪9.38%‬
Return on Equity
‪12.52%‬
Ownership
Shares Outstanding
82.60M
Float
30.58M
Held by Insiders
‪57.08%‬
Held by Institutions
‪19.69%‬
Price stats
Beta
‪0.63‬
50-Day Avg
‪161.74‬
200-Day Avg
‪150.33‬
Dividends
Payout Ratio
‪24.54%‬
Frequency
Annual
Peers - 0MH6 - Ipsen S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0MH6LSEIpsen S.A.14.36BMarket Cap+34.71%52-week change33.21P/E (Trailing)‪13.69%‬Profit Margin
- HLNLSEHaleon plc3.25TMarket Cap+1.98%52-week change20.53P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change18.82P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc341.00BMarket Cap+2.60%52-week change—P/E (Trailing)‪-10.78%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB168.30BMarket Cap+37.06%52-week change47.81P/E (Trailing)‪15.54%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited159.03BMarket Cap-23.50%52-week change178.00P/E (Trailing)‪3.25%‬Profit Margin
- 0O14LSEMerck KGaA64.57BMarket Cap+22.53%52-week change19.55P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - 0MH6 - Ipsen S.A.
About
Ipsen S.A. is a French biopharmaceutical company headquartered in Paris, specializing in the development and commercialization of transformative medicines across three core therapeutic areas: oncology, rare diseases, and neuroscience. Founded in 1929 by Dr. Henri Beaufour as a family business, it has evolved over…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
